Testing a new artificial heart valve for aortic valve disease
Part of Heart & circulation clinical trials.
This trial tests a new polymer heart valve for people with severe aortic valve narrowing or leakage. It aims to see if the valve is safe and works well as a replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe aortic valve stenosis (tightening) or regurgitation (leaking), as shown on an echo
- You are eligible for planned surgical valve replacement according to current guidelines
- You do not have other serious heart valve problems needing surgery
- You do not have severe heart failure, recent heart attack, stroke, or other major organ conditions
- You can understand the study and agree to follow all procedures and follow-ups
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of artificial heart valve made of polymer (a special plastic-like material) for people with severe aortic valve disease. It aims to see if the valve is safe and works well, giving you an option for a replacement valve that might last longer.
This trial tests a new type of aortic heart valve (PoliaValve) for people with severe aortic valve disease who need valve replacement surgery. If you qualify, you will receive the experimental valve and be followed for one year to see how well it works.
This trial tests how well a new replacement heart valve works and how safe it is. You might qualify if you need a planned first-time aortic valve replacement and are 60-70 years old (or younger if you cannot take blood thinners).
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.